Who owns PHARVARIS N V?
- Ticker: PHVS
- CUSIP Number: n69605108
Tip: Access positions for across all investors
Analyze quarterly positions in Pharvaris N V with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pharvaris N V stock
Who bought or sold PHARVARIS N V this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| General Atlantic | 8.0M | $200M | 7% | Sep 2025 |
|
| FMR | 6.4M | $160M | 18% | Sep 2025 |
|
| Foresite Capital Management IV | 4.8M | $119M | 8% | Sep 2025 |
|
| venBio Partners | 4.6M | $116M | 8% | Sep 2025 |
|
| Viking Global Investors | 3.7M | $91M | 0% | Sep 2025 |
|
| EQT Fund Management S.a r.l. | 3.4M | $85M | 100% | Sep 2025 |
|
| Bain Capital Life Sciences Investors | 3.2M | $79M | -4% | Sep 2025 |
|
| Deerfield Management Company | 2.4M | $61M | 21% | Sep 2025 |
|
| Commodore Capital | 2.4M | $60M | 27% | Sep 2025 |
|
| Paradigm Biocapital Advisors | 1.8M | $46M | 73% | Sep 2025 |
|
| Novo A/S | 1.8M | $44M | 1% | Sep 2025 |
|
| Wellington Management Company | 1.7M | $43M | 100% | Sep 2025 |
|
| Cormorant Asset Management | 1.4M | $34M | -6% | Sep 2025 |
|
| Saturn V Capital Management | 886k | $22M | 100% | Sep 2025 |
|
| 5AM Venture Management | 798k | $20M | 0% | Sep 2025 |
|
| Sofinnova Ventures | 740k | $19M | 26% | Sep 2025 |
|
| Octagon Capital Advisors | 723k | $18M | 7% | Sep 2025 |
|
| Kynam Capital Management | 675k | $17M | 100% | Sep 2025 |
|
| VR Adviser | 675k | $17M | -67% | Sep 2025 |
|
| Soleus Capital Management | 647k | $16M | -12% | Sep 2025 |
|
| Balyasny Asset Management | 626k | $16M | 100% | Sep 2025 |
|
| Rock Springs Capital Management | 623k | $16M | 0% | Sep 2025 |
|
| Point72 Asset Management | 519k | $13M | 1281% | Sep 2025 |
|
| BlackRock | 414k | $10M | 106% | Sep 2025 |
|
| Baker Bros. Advisors | 375k | $9.4M | 100% | Sep 2025 |
|
| Patient Square Capital | 345k | $8.6M | 41% | Sep 2025 |
|
| Polar Capital Holdings | 265k | $6.6M | 100% | Sep 2025 |
|
| Ikarian Capital | 210k | $5.2M | 100% | Sep 2025 |
|
| Integral Health Asset Management | 200k | $5.0M | 100% | Sep 2025 |
|
| Polygon Management | 195k | $4.9M | 3% | Sep 2025 |
|
| Silverarc Capital Management | 184k | $4.6M | 100% | Sep 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 155k | $3.9M | 100% | Sep 2025 |
|
| Logos Global Management | 150k | $3.7M | 100% | Sep 2025 |
|
| State Street Corporation | 143k | $3.6M | 52% | Sep 2025 |
|
| Boothbay Fund Management | 135k | $3.4M | 735% | Sep 2025 |
|
| UBS Group | 131k | $3.3M | 3393% | Sep 2025 |
|
| Citadel Advisors | 130k | $3.2M | 344% | Sep 2025 |
|
| Alyeska Investment Group | 125k | $3.1M | 100% | Sep 2025 |
|
| Sphera Funds Management | 119k | $3.0M | -61% | Sep 2025 |
|
| Millennium Management | 107k | $2.7M | 702% | Sep 2025 |
|
| TD Asset Management | 104k | $2.6M | 5% | Sep 2025 |
|
| Woodline Partners | 100k | $2.5M | 100% | Sep 2025 |
|
| Geode Capital Management | 79k | $2.0M | 45% | Sep 2025 |
|
| Northern Trust | 78k | $1.9M | -18% | Sep 2025 |
|
| Tudor Investment Corporation | 78k | $1.9M | 100% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 60k | $1.5M | 22% | Sep 2025 |
|
| Morgan Stanley | 60k | $1.1M | 100% | Jun 2025 |
|
| Deutsche Bank Aktiengesellschaft | 52k | $1.3M | 84% | Sep 2025 |
|
| Swiss National Bank | 42k | $1.1M | 61% | Sep 2025 |
|
| Amundi | 42k | $965k | 51% | Sep 2025 |
|
| ADAR1 Capital Management | 34k | $851k | 0% | Sep 2025 |
|
| Marshall Wace | 27k | $676k | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 27k | $676k | 958% | Sep 2025 |
|
| Hrt Financial | 26k | $653k | 100% | Sep 2025 |
|
| California State Teachers Retirement System | 24k | $585k | 67% | Sep 2025 |
|
| D. E. Shaw & Co | 23k | $571k | 100% | Sep 2025 |
|
| Legal & General Group | 23k | $566k | 96% | Sep 2025 |
|
| Jane Street | 21k | $529k | 100% | Sep 2025 |
|
| Vanguard Group | 19k | $482k | 100% | Sep 2025 |
|
| Nuveen | 17k | $424k | 100% | Sep 2025 |
|
| Palumbo Wealth Management | 17k | $415k | 14% | Sep 2025 |
|
| Birchview Capital | 15k | $370k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 15k | $361k | 100% | Sep 2025 |
|
| Schroder Investment Management Group | 12k | $293k | 100% | Sep 2025 |
|
| Cubist Systematic Strategies | 12k | $290k | 354% | Sep 2025 |
|
| Two Sigma Investments | 11k | $265k | 100% | Sep 2025 |
|
| Alliancebernstein | 9.0k | $224k | 100% | Sep 2025 |
|
| XTX Topco | 8.2k | $205k | 100% | Sep 2025 |
|
| Virtus Investment Advisers | 6.6k | $165k | 21% | Sep 2025 |
|
| Ohio Pers | 6.3k | $156k | 39% | Sep 2025 |
|
| Klp Kapitalforvaltning As | 5.8k | $145k | 0% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 5.5k | $137k | 100% | Sep 2025 |
|
| Bnp Paribas Investment Partners | 3.3k | $81k | 0% | Sep 2025 |
|
| China Universal Asset Management | 3.0k | $75k | 100% | Sep 2025 |
|
| Quarry | 442.00 | $11k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 413.00 | $10k | 15% | Sep 2025 |
|
| Centerpoint Advisors | 100.00 | $2.0k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 76.00 | $2.0k | 31% | Sep 2025 |
|
| SBI Securities | 3.00 | $75.000000 | 200% | Sep 2025 |
|
| Point72 Asia | 1.00 | $25.000000 | -100% | Sep 2025 |
|
Who sold out of Pharvaris N V?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Rosalind Advisors | Jun 2025 | 224k | $3.9M |
| Ubs Global Asset Management Americas | Jun 2025 | 55k | $975k |
| ALPS Advisors | Jun 2025 | 29k | $517k |
| HighVista Strategies | Jun 2025 | 24k | $418k |
| Barclays | Jun 2025 | 2.8k | $49k |
| Wells Fargo & Company | Jun 2025 | 1.0k | $18k |